Allium Financial Advisors’s AbbVie ABBV Stock Holding History

Allium Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$820K	Sell	3,258 -262	-7%	-$56.4K	0.54%	34
2026 Q1	$766K	Buy	3,520 +1	+0%	+$222	0.61%	31
2025 Q4	$804K	Sell	3,519 -311	-8%	-$70.8K	0.64%	28
2025 Q3	$887K	Sell	3,830 -77	-2%	-$15.7K	0.73%	27
2025 Q2	$725K	Sell	3,907 -116	-3%	-$21.6K	0.63%	27
2025 Q1	$843K	Buy	+4,023	New	+$782K	0.77%	24

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Allium Financial Advisors's ABBV Position: Q2 2026 in Review

Allium Financial Advisors reduced its AbbVie (ABBV) stake by 7.4% in Q2 2026, selling an estimated $56.4K and leaving 3,258 shares worth $820K. The position accounts for 0.54% of the portfolio, ranked #34.

Allium Financial Advisors first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $887K in Q3 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Allium Financial Advisors held 3,258 shares of AbbVie worth $820K as of Q2 2026.
Allium Financial Advisors sold 262 AbbVie shares in Q2 2026, an estimated $56.4K.
AbbVie made up 0.54% of Allium Financial Advisors's portfolio in Q2 2026, its #34 holding.
Allium Financial Advisors first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
Allium Financial Advisors's AbbVie position peaked at $887K in Q3 2025.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Allium Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.